fda glp-1 compounded warning september 2025 cracks down on 'misleading' GLP-1s by telehealth companies - Indianapolis News | Indiana Weather | Indiana Traffic September 2, 2025: U.S. compounding

It is investigational (not FDA-approved on its own)

Boosting Energy and Combating Fatigue: Because NAD plays a key role in cellular energy (ATP) production, individuals struggling with persistent tiredness or chronic fatigue may seek out NAD injections

Faster ramp, higher ceiling, more side effect risk

Nat Commun 13:6558 Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, Du XJ (2006) Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

Cold or room-temperature beverages are generally better tolerated than hot liquids during symptomatic periods

Analysis of FAERS data from 2004 to 2020 revealed significant associations between GLP-1 RA and various neoplasms, notably medullary thyroid cancer (PRR, 27.43), papillary thyroid cancer (PRR, 8.68), malignant pancreatic neoplasms (PRR, 9.86), and pancreatic neuroendocrine neoplasms (PRR, 2.86) [52]